Search

everythinglearnresearchcommunity

for

Search:↓

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

A girl with Denys-Drash syndrome was misdiagnosed due to biotin affecting her hormone test results.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Gene mutations can cause problems in male genital development.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Melatonin may help with sleep issues, depression, and cancer, but more research is needed.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Care for gender-dysphoric Veterans can be improved with a consistent, team-based approach.